{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T16:49:12Z","timestamp":1791132552508,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["New Biotechnology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.nbt.2013.01.007","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T23:09:35Z","timestamp":1360019375000},"page":"381-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":85,"title":["Genetics and epigenetics of liver cancer"],"prefix":"10.1016","volume":"30","author":[{"given":"Cigdem","family":"Ozen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokhan","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alper Tunga","family":"Dagcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Cevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysegul","family":"Ors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umur","family":"Keles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hande","family":"Topel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbt.2013.01.007_bib0005","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.nbt.2013.01.007_bib0010","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0015","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1053\/j.gastro.2008.02.090","article-title":"Diagnosis and treatment of hepatocellular carcinoma","volume":"134","author":"El-Serag","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0020","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.nbt.2013.01.007_bib0025","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mpo.10180","article-title":"Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects","volume":"39","author":"Buendia","year":"2002","journal-title":"Medical and Pediatric Oncology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/ng.2256","article-title":"Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma","volume":"44","author":"Guichard","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.nbt.2013.01.007_bib0035","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/286533a0","article-title":"Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma","volume":"286","author":"Brechot","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.nbt.2013.01.007_bib0040","first-page":"211","article-title":"Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC)","volume":"10","author":"Brechot","year":"2000","journal-title":"Seminars in Cell Biology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0045","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ng.2291","article-title":"Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators","volume":"44","author":"Fujimoto","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.nbt.2013.01.007_bib0050","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1073\/pnas.87.5.1973","article-title":"Abnormal structure and expression of p53 gene in human hepatocellular carcinoma","volume":"87","author":"Bressac","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.nbt.2013.01.007_bib0055","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-2007-1007113","article-title":"Genetic aspects of hepatocellular carcinogenesis","volume":"19","author":"Ozturk","year":"1999","journal-title":"Seminars in Liver Disease"},{"key":"10.1016\/j.nbt.2013.01.007_bib0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.canlet.2008.10.048","article-title":"Senescence and immortality in hepatocellular carcinoma","volume":"286","author":"Ozturk","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.nbt.2013.01.007_bib0065","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/ng.2391","article-title":"Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma","volume":"44","author":"Huang","year":"2012","journal-title":"Nature Genetics"},{"key":"10.1016\/j.nbt.2013.01.007_bib0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.gde.2012.02.008","article-title":"Cancer epigenomics: beyond genomics","volume":"22","author":"Sandoval","year":"2012","journal-title":"Current Opinion in Genetics and Development"},{"key":"10.1016\/j.nbt.2013.01.007_bib0075","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nm.2305","article-title":"Cancer epigenetics reaches mainstream oncology","volume":"17","author":"Rodriguez-Paredes","year":"2011","journal-title":"Nature Medicine"},{"key":"10.1016\/j.nbt.2013.01.007_bib0080","article-title":"Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma","author":"Pogribny","year":"2012","journal-title":"Cancer Letters"},{"key":"10.1016\/j.nbt.2013.01.007_bib0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1477-2574.2011.00303.x","article-title":"Clinical implications of DNA methylation in hepatocellular carcinoma","volume":"13","author":"Sceusi","year":"2011","journal-title":"HPB (Oxford)"},{"key":"10.1016\/j.nbt.2013.01.007_bib0090","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/msb.2010.58","article-title":"microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma","volume":"6","author":"Burchard","year":"2010","journal-title":"Molecular Systems Biology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0095","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1158\/1078-0432.CCR-11-2322","article-title":"Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib","volume":"18","author":"Lachenmayer","year":"2012","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.nbt.2013.01.007_bib0100","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/sj.onc.1209283","article-title":"Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumourous tissues","volume":"25","author":"Murakami","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.nbt.2013.01.007_bib0105","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.nbt.2013.01.007_bib0110","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gut.2010.231993","article-title":"EZH2 protein: a promising immunomarker for the detection of hepatocellular carcinomas in liver needle biopsies","volume":"60","author":"Cai","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.nbt.2013.01.007_bib0115","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/labinvest.2008.52","article-title":"The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma","volume":"88","author":"Sasaki","year":"2008","journal-title":"Laboratory Investigation"},{"key":"10.1016\/j.nbt.2013.01.007_bib0120","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1158\/0008-5472.CAN-10-3342","article-title":"EZH2-mediated concordant repression of Wnt antagonists promotes beta-catenin-dependent hepatocarcinogenesis","volume":"71","author":"Cheng","year":"2011","journal-title":"Cancer Research"},{"key":"10.1016\/j.nbt.2013.01.007_bib0125","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.25679","article-title":"Enhancer of zeste homolog 2 epigenetically silences multiple tumour suppressor microRNAs to promote liver cancer metastasis","volume":"56","author":"Au","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0130","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/hep.24563","article-title":"Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumour growth through enhancer of zeste homolog 2 in humans","volume":"54","author":"Yang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0135","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1349-7006.2009.01431.x","article-title":"Bmi-1 gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression","volume":"101","author":"Effendi","year":"2010","journal-title":"Cancer Science"},{"key":"10.1016\/j.nbt.2013.01.007_bib0140","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2008.10.047","article-title":"HDAC expression and clinical prognosis in human malignancies","volume":"280","author":"Weichert","year":"2009","journal-title":"Cancer Letters"},{"key":"10.1016\/j.nbt.2013.01.007_bib0145","doi-asserted-by":"crossref","first-page":"e14460","DOI":"10.1371\/journal.pone.0014460","article-title":"Identification of histone deacetylase 3 as a biomarker for tumour recurrence following liver transplantation in HBV-associated hepatocellular carcinoma","volume":"5","author":"Wu","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbt.2013.01.007_bib0150","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00428-011-1103-0","article-title":"Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC","volume":"459","author":"Quint","year":"2011","journal-title":"Virchows Archiv"},{"key":"10.1016\/j.nbt.2013.01.007_bib0155","doi-asserted-by":"crossref","first-page":"e34265","DOI":"10.1371\/journal.pone.0034265","article-title":"HDAC1 inactivation induces mitotic defect and caspase-independent autophagic cell death in liver cancer","volume":"7","author":"Xie","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.nbt.2013.01.007_bib0160","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1002\/hep.24606","article-title":"The histone deacetylase 4\/SP1\/microrna-200a regulatory network contributes to aberrant histone acetylation in hepatocellular carcinoma","volume":"54","author":"Yuan","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0165","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1053\/hupa.2003.5","article-title":"Expression of DNA methyltransferases in multistep hepatocarcinogenesis","volume":"34","author":"Choi","year":"2003","journal-title":"Human Pathology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0170","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1053\/jhep.2001.22507","article-title":"Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis","volume":"33","author":"Saito","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.nbt.2013.01.007_bib0175","doi-asserted-by":"crossref","first-page":"e17794","DOI":"10.1371\/journal.pone.0017794","article-title":"ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth","volume":"6","author":"Li","year":"2011","journal-title":"PLoS ONE"}],"container-title":["New Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678413000101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871678413000101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:53:26Z","timestamp":1761731606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871678413000101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1871678413000101"],"URL":"https:\/\/doi.org\/10.1016\/j.nbt.2013.01.007","relation":{},"ISSN":["1871-6784"],"issn-type":[{"value":"1871-6784","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics and epigenetics of liver cancer","name":"articletitle","label":"Article Title"},{"value":"New Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbt.2013.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}